Scientists identify natural defence cells that impede chemotherapy treatment

April 27, 2011

As part of the body’s front-line defences against infection, white blood cells called macrophages often infiltrate tumours in great numbers. However, according to new research published in the scientific journal Cancer Discovery, these cells can make tumours more resistant to chemotherapy treatment.

The international team of scientists involved in the discovery have shown that a depletion of macrophages (TAM) in progressing breast tumours improved the anti-tumour effectiveness of paclitaxel, a chemotherapeutic agent.

When the team treated TAM-depleted tumours (which also had fewer blood vessels, greater numbers of cytotoxic T and more signs of tumour destruction) with paclitaxel they witnessed a greater reduction in the size of the tumour.

“Our findings offer a new approach to improving the efficacy of established agents,” said Dr Donal Brennan from the UCD Conway Institute, who, along with his UCD colleague Professor William Gallagher, was part of the international team led by Professor Lisa Coussens from the University of California San Francisco.

“In addition to identifying a novel therapeutic agent, we have also developed a predicitive inflammatory signature which will identify patients likely to respond to anti-CSF1R therapy,” said Dr Brennan.

“The inflammatory signature will hopefully allow us to run biomarker driven clinical trials, which should allow for rapid translation of these findings into breast cancer clinics over the next few years.”

Commenting on the significance of the findings, a news article in the leading scientific journal Nature said: these results “add weight to an emerging compelling case for deciphering the complexity of leukocyte infiltrates in breast cancer.” And, “this may provide clinically relevant indications of the likely response to chemotherapy and thus patient survival.”

The predicitive signature developed during this research project took advantage of a novel image analysis approach, IHC-MARK, developed by Professor Gallagher’s team at the UCD Conway Institute, to quantify inflammatory cell density in cancer tissues. The method is currently being in-licenced to the spin-out company, OncoMark Limited, which is utilising such automated image analysis approaches for development of companion diagnostics.

More information: “Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy” published in Cancer Discovery. David G. DeNardo; Donal J Brennan, Elton Rexhepaj; Brian Ruffell; Stephen L. Shiao; Stephen F. Madden; William M Gallagher, Nikhil Wadhwani; Scott D. Keil; Sharfaa A. Junaid; Hope S. Rugo; E. Shelley Hwang; Karin Jirstrom; Brian L. West; and Lisa M. Coussens.

Related Stories

Recommended for you

Study provides insight into link between two rare tumor syndromes

August 22, 2017
UCLA researchers have discovered that timing is everything when it comes to preventing a specific gene mutation in mice from developing rare and fast-growing cancerous tumors, which also affects young children. This mutation ...

Retaining one normal BRCA gene in breast, ovarian cancers influences patient survival

August 22, 2017
Determining which cancer patients are likely to be resistant to initial treatment is a major research effort of oncologists and laboratory scientists. Now, ascertaining who might fall into that category may become a little ...

Zebrafish larvae could be used as 'avatars' to optimize personalized treatment of cancer

August 21, 2017
Portuguese scientists have for the first time shown that the larvae of a tiny fish could one day become the preferred model for predicting, in advance, the response of human malignant tumors to the various therapeutic drugs ...

Scientists discover vitamin C regulates stem cell function, curbs leukemia development

August 21, 2017
Not much is known about stem cell metabolism, but a new study from the Children's Medical Center Research Institute at UT Southwestern (CRI) has found that stem cells take up unusually high levels of vitamin C, which then ...

Searching for the 'signature' causes of BRCAness in breast cancer

August 21, 2017
Breast cancer cells with defects in the DNA damage repair-genes BRCA1 and BRCA2 have a mutational signature (a pattern of base swaps—e.g., Ts for Gs, Cs for As—throughout a genome) known in cancer genomics as "Signature ...

How a non-coding RNA encourages cancer growth and metastasis

August 21, 2017
A mechanism that pushes a certain gene to produce a non-coding form of RNA instead of its protein-coding alternative can promote the growth of cancer, report researchers at the Medical University of South Carolina (MUSC) ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Apr 29, 2011
I'd like to know what is good about knocking out the body's immune defenses OR about poisoning a tumor and with it, the host body.

Does anyone see the utter senselessness of this approach?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.